TY  - JOUR
AU  - García-Arriaza, Juan
AU  - Garaigorta, Urtzi
AU  - Pérez, Patricia
AU  - Lázaro-Frías, Adrián
AU  - Zamora, Carmen
AU  - Gastaminza, Pablo
AU  - Del Fresno, Carlos
AU  - Casasnovas, José M
AU  - Sorzano, Carlos Óscar S
AU  - Sancho, David
AU  - Esteban, Mariano
PY  - 2021
DO  - 10.1128/JVI.02260-20
UR  - http://hdl.handle.net/20.500.12105/15160
AB  - Vaccines against SARS-CoV-2, the causative agent of the COVID-19 pandemic, are urgently needed. We developed two COVID-19 vaccines based on modified vaccinia virus Ankara (MVA) vectors expressing the entire SARS-CoV-2 spike (S) protein (MVA-CoV2-S);...
LA  - eng
PB  - American Society for Microbiology (ASM)
TI  - COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice.
TY  - journal article
ER  -